Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Boston Scientific Pauses Watchman FLX Sales In Europe

This article was originally published in The Gray Sheet

Executive Summary

Initial rates of device embolizations have convinced the firm to temporarily halt sales of the next-generation FLX left atrial appendage closure device to assess physician training needs. The move, four-and-a-half months after the device was launched on a limited basis in Europe, does not impact sales of the current-generation Watchman system.



Related Companies